Vitiligo is a disorder characterized by the development of depigmented patches and macules. Patients with extensive involvement may opt for complete depigmentation using monobenzyl ether of hydroquinone (MBEH).1 However, after depigmentation, a subset of patients note repigmentation that is significantly darker than their original skin tone and is resistant to treatment with MBEH.2 Here we present a vitiligo patient who had recalcitrant repigmentation after depigmentation with MBEH, which was responsive to treatment with the 532-nm Q-switched neodymium-doped yttrium aluminum garnet (QS Nd:Yag) laser.
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182,alsfakia@gmail.com
Αναζήτηση αυτού του ιστολογίου
Πληροφορίες
Ετικέτες
Τετάρτη 11 Ιουλίου 2018
Use of the 532-nm Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of recalcitrant repigmentation in vitiligo
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.